Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Resting-state Brain Activity Changes Associated with Tardive Dyskinesia in Patients with Schizophrenia: Fractional Amplitude of Low-frequency Fluctuation Decreased in the Occipital Lobe.

Zhang P, Li Y, Fan F, Li CR, Luo X, Yang F, Yao Y, Tan Y.

Neuroscience. 2018 Aug 10;385:237-245. doi: 10.1016/j.neuroscience.2018.06.014. Epub 2018 Jun 20.

PMID:
29909076
2.

Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity.

Wang YM, Zou LQ, Xie WL, Yang ZY, Zhu XZ, Cheung EFC, Sørensen TA, Møller A, Chan RCK.

Psychiatry Res Neuroimaging. 2018 Jun 30;276:65-72. doi: 10.1016/j.pscychresns.2018.03.009. Epub 2018 Mar 28.

PMID:
29628272
3.

The neuropathological study of myelin oligodendrocyte glycoprotein in the temporal lobe of schizophrenia patients.

Marui T, Torii Y, Iritani S, Sekiguchi H, Habuchi C, Fujishiro H, Oshima K, Niizato K, Hayashida S, Masaki K, Kira J, Ozaki N.

Acta Neuropsychiatr. 2018 Aug;30(4):232-240. doi: 10.1017/neu.2018.6. Epub 2018 Mar 22.

PMID:
29564992
4.

Neural circuit of verbal humor comprehension in schizophrenia - an fMRI study.

Adamczyk P, Wyczesany M, Domagalik A, Daren A, Cepuch K, Błądziński P, Cechnicki A, Marek T.

Neuroimage Clin. 2017 Jun 3;15:525-540. doi: 10.1016/j.nicl.2017.06.005. eCollection 2017.

5.

Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.

Wesseling H, Gottschalk MG, Bahn S.

Int J Neuropsychopharmacol. 2014 Oct 31;18(1). pii: pyu015. doi: 10.1093/ijnp/pyu015.

6.

Seroprevalence of autoantibodies against brain antigens in health and disease.

Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stöcker W, Ehrenreich H.

Ann Neurol. 2014 Jul;76(1):82-94. doi: 10.1002/ana.24189. Epub 2014 Jun 23.

PMID:
24853231
7.

In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.

Farooq SM, Ashour HM.

Brain Behav Immun. 2014 Jan;35:64-9. doi: 10.1016/j.bbi.2013.09.016. Epub 2013 Oct 1.

PMID:
24095895
8.

Decreased resting-state interhemispheric coordination in first-episode, drug-naive paranoid schizophrenia.

Guo W, Xiao C, Liu G, Wooderson SC, Zhang Z, Zhang J, Yu L, Liu J.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:14-9. doi: 10.1016/j.pnpbp.2013.09.012. Epub 2013 Sep 27.

PMID:
24075897
9.

The association of white matter volume in psychotic disorders with genotypic variation in NRG1, MOG and CNP: a voxel-based analysis in affected individuals and their unaffected relatives.

Cannon DM, Walshe M, Dempster E, Collier DA, Marshall N, Bramon E, Murray RM, McDonald C.

Transl Psychiatry. 2012 Oct 9;2:e167. doi: 10.1038/tp.2012.82.

10.

Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia.

Matthews PR, Eastwood SL, Harrison PJ.

PLoS One. 2012;7(6):e38211. doi: 10.1371/journal.pone.0038211. Epub 2012 Jun 1.

11.

Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder.

Barley K, Dracheva S, Byne W.

Schizophr Res. 2009 Jul;112(1-3):54-64. doi: 10.1016/j.schres.2009.04.019. Epub 2009 May 17.

PMID:
19447584
12.

Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis.

Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Marangoni S, Novello JC, Maccarrone G, Turck CW, Dias-Neto E.

J Neural Transm (Vienna). 2009 Mar;116(3):275-89. doi: 10.1007/s00702-008-0156-y. Epub 2008 Nov 26.

PMID:
19034380
13.

Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia.

Mitkus SN, Hyde TM, Vakkalanka R, Kolachana B, Weinberger DR, Kleinman JE, Lipska BK.

Schizophr Res. 2008 Jan;98(1-3):129-38. Epub 2007 Oct 26.

14.

Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?

Sokolov BP.

Int J Neuropsychopharmacol. 2007 Aug;10(4):547-55. Epub 2007 Feb 12. Review.

PMID:
17291372
15.

Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia.

Zai G, King N, Wigg K, Couto J, Wong GW, Honer WG, Barr CL, Kennedy JL.

Genes Brain Behav. 2005 Feb;4(1):2-9.

16.

A family-based association study of the MOG gene with schizophrenia in the Chinese population.

Liu X, Qin W, He G, Yang Y, Chen Q, Zhou J, Li D, Gu N, Xu Y, Feng G, Sang H, Hao X, Zhang K, Wang S, He L.

Schizophr Res. 2005 Mar 1;73(2-3):275-80.

PMID:
15653272
18.

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.

Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB, Starkey M, Webster MJ, Yolken RH, Bahn S.

Lancet. 2003 Sep 6;362(9386):798-805.

PMID:
13678875

Supplemental Content

Loading ...
Support Center